Overview
-
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
₹390.83
▼ 1.84
(0.47%)
| Instrument Name | Watchlist | Investment Date | % Holding | No of Units | Value (₹ Cr) | Asset Type | Industry Name |
|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical ... | 31 Aug 2026 | 8.25% | 6,00,000 | ₹119.09 Cr | Equity | Pharmaceuticals | |
 Divis Laboratories Ltd | 31 Aug 2026 | 6.21% | 94,707 | ₹89.66 Cr | Equity | Pharmaceuticals | |
 Net CA & Others | 31 Aug 2026 | 5.71% | 0 | ₹82.41 Cr | Net CA & Others | Debt Others | |
 Ajanta Pharma Ltd | 31 Aug 2026 | 4.74% | 1,90,000 | ₹68.44 Cr | Equity | Pharmaceuticals | |
 Gland Pharma Ltd | 31 Aug 2026 | 3.70% | 1,85,000 | ₹53.39 Cr | Equity | Pharmaceuticals | |
| Dr Reddys Laborator... | 31 Aug 2026 | 3.62% | 4,53,143 | ₹52.31 Cr | Equity | Pharmaceuticals | |
| Alkem Laboratories Ltd | 31 Aug 2026 | 3.29% | 89,000 | ₹47.43 Cr | Equity | Pharmaceuticals | |
| Apollo Hospitals En... | 31 Aug 2026 | 3.27% | 53,000 | ₹47.16 Cr | Equity | Healthcare | |
 Max Healthcare Inst... | 31 Aug 2026 | 3.10% | 4,30,000 | ₹44.81 Cr | Equity | Healthcare | |
 Lupin Ltd | 31 Aug 2026 | 3.09% | 2,03,834 | ₹44.61 Cr | Equity | Pharmaceuticals |
Funds in the same category by AUM
You can invest in UTI-Healthcare Fund - Direct (G) through a lump sum investment or a monthly SIP. The minimum lump sum investment is ₹5,000 and the minimum SIP amount is ₹500.
The latest NAV of UTI-Healthcare Fund - Direct (G) is ₹390.83.
UTI-Healthcare Fund - Direct (G) manages assets worth ₹1,443.57 Cr.
The expense ratio of UTI-Healthcare Fund - Direct (G) is 1.26%.
The exit load applicable on UTI-Healthcare Fund - Direct (G) is 1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment..
As per the riskometer, UTI-Healthcare Fund - Direct (G) carries Very High risk.
UTI-Healthcare Fund - Direct (G) is managed by UTI Mutual Fund.
UTI-Healthcare Fund - Direct (G) belongs to the Sectoral Fund category.
UTI-Healthcare Fund - Direct (G) is benchmarked against the BSE Healthcare TRI.
UTI-Healthcare Fund - Direct (G) has no lock-in period, so units can be redeemed at any time subject to the applicable exit load.
UTI-Healthcare Fund - Direct (G) was launched on 01 Jan 2013.
After the initial investment, you can invest in UTI-Healthcare Fund - Direct (G) in further multiples of ₹1,000.
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
01 Jan 2013
₹1,443.57 Cr
₹390.83
₹500
₹5,000
Very High
1.26%
17.68
0.74
1.17
4.60
0.61
0.11
30.63
This fund has Very High risk.
Returns over a year are annualised (per year, compounded).
Calendar year return from the first period shown through each year.
| Company | Watchlist | Sector | Activity | Investment Date | % Holding | Market Value | Shares | Asset Type | Rating |
|---|---|---|---|---|---|---|---|---|---|
 Blue Jet Healthcare... | Pharmaceuticals -... | Bought | 31 Jul 2026 | 1.13% | ₹15.47 Cr | 2,47,036 | Equity | EQUITY | |
| Manipal Health Ente... | Hospitals / Medic... | Bought | 31 Jul 2026 | 0.91% | ₹12.54 Cr | 2,12,525 | Equity | EQUITY | |
 Krishna Institute o... | Hospitals / Medic... | Sold | 31 Jul 2026 | 0.81% | ₹11.05 Cr | 1,37,321 | Equity | EQUITY |
| Fund | 1Y | 3Y | Expense Ratio | Fund Size | Alpha | Sharpe | Risk | |
|---|---|---|---|---|---|---|---|---|
 SBI Healthcare Opportunities ... | 22.78% | 24.99% | 1.04% | ₹5,796.42 Cr | 17.41 | 1.27 | Very High | |
 Mirae Asset Healthcare Fund -... | 22.11% | 24.02% | 0.61% | ₹3,555.18 Cr | 16.80 | 1.10 | Very High | |
 HDFC Pharma and Healthcare Fu... | 28.36% | — | 1.08% | ₹3,310.64 Cr | 24.17 | 1.58 | Very High | |
 Tata India Pharma & Healthcar... | 10.30% | 20.72% | 1.00% | ₹1,565.28 Cr | 14.43 | 0.95 | Very High | |
| UTI-Healthcare Fund - Direct (G) | 18.79% | 25.04% | 1.26% | ₹1,443.57 Cr | 17.68 | 1.17 | Very High | |
 Aditya Birla SL Pharma & Heal... | 19.32% | 22.43% | 1.02% | ₹1,102.73 Cr | 16.00 | 1.10 | Very High | |
 WhiteOak Capital Pharma and H... | 24.81% | — | 1.13% | ₹902.24 Cr | 19.86 | 1.14 | Very High |
Funds in the same category by AUM
| Fund | Watchlist | AMC | NAV | Fund Size | Expense Ratio | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
 ICICI Pru Technology Fund... | ICICI Prudential Mutual Fund | ₹194.12 | ₹13,660.98 Cr | 1.22% | -11.08% | 4.46% | 1.93% | |
| HDFC Defence Fund - Direc... | HDFC Mutual Fund | ₹31.08 | ₹11,477.59 Cr | 0.89% | 23.83% | 38.03% | — | |
| ICICI Pru Banking & Finan... | ICICI Prudential Mutual Fund | ₹145.07 | ₹11,330.58 Cr | 1.23% | -3.67% | 9.21% | 8.98% | |
| SBI Banking & Financial S... | SBI Mutual Fund | ₹47.70 | ₹10,872.95 Cr | 1.20% | -0.70% | 14.93% | 11.76% | |
| Tata Digital India Fund -... | Tata Mutual Fund | ₹46.47 | ₹10,322.02 Cr | 0.67% | -13.66% | 3.50% | 1.77% | |
| UTI-Healthcare Fund - Dir... | UTI Mutual Fund | ₹390.83 | ₹1,443.57 Cr | 1.26% | 18.79% | 25.04% | 16.25% |